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INTRODUCTION 
 
                        The prime responsibility and aim of any anaesthesiologist is the 
maintenance of airway .From the time endotracheal intubation was introduced, 
undue  problems have occurred due to failed ventilation and  tracheal  intubation.  
Many studies have proved that airway mismanagement occurs  in most cases due 
to lack of proper expertise and equipments.   Supraglottic airway devices  { SAD 
} are one such equipments  which are  helpful in patients with difficult airways 
and in emergency situations  and in cardiopulmonary resuscitations
1.
 The large 
majority of general anaesthetics  are in recent days  delivered with supraglottic 
airway devices which have become a unavoidable  resource  in difficult  airway  
algorithm .Some supraglottic airway devices  are used for blind or fibreoptic 
bronchoscopy {FOB} guided intubation  in the airway management  . They can 
be efficiently used as  rescue  airway devices   in patients  with difficult airway   
and their use has increased in anaesthesia practice  and emergency medical 
services
29
 . 
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AIM OF THE STUDY 
    To compare supraglottic airway devices , I-GEL and INTUBATING 
LMA { ILMA  } for ease of insertion and as a conduit for blind endotracheal 
intubation. 
   OBJECTIVES OF THE STUDY 
 
1}  To study the effectiveness of Supraglottic airway devices I-GEL And 
ILMA {INTUBATING LARYNGEAL MASK AIRWAY}  in emergency 
airway  management
9
] 
2} To evaluate the feasibility for blind endotracheal intubation using I-GEL  
and ILMA {INTUBATING LARYNGEAL MASK AIRWAY}  as 
conduits  in difficult intubation conditions 
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SUPRAGLOTTIC AIRWAY DEVICES 
 Supraglottic airway devices  comprises    a  important  source  of airway 
equipments  that promote  oxygenation and ventilation without  the need for 
endotracheal intubation .The word “supraglottic” means  above the glottis and it 
covers the  larynx . These   products are also called as “extraglottic “ devices by 
some authors
13
.        
Supraglottic  airway devices are intermediate between the face mask and 
endotracheal tube{ ETT}   in terms of anatomical position , size , invasiveness , 
technique and  skills in insertion etc .These  devices  function  outside the 
trachea but helps in  providing   a airtight airway
2 
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HISTORY AND  EVOLUTION OF SUPRAGLOTTIC  
AIRWAY DEVICES 
           Dr.Archie Brain developed LARYNGEAL MASK AIRWAY { LMA }  
in 1982 at Royal London hospital as a modification of the Goldmann dental 
mask.     He invented and developed the LMA classic by modifying goldman 
nasal mask which he fused with a obliquely cut endotracheal tube   (ETT). The  
device was developed to attenuate the need for ETT placement and thereby 
reduce airway morbidity due to tracheal intubation.  Many prototypes of 
laryngeal mask airway {LMA} were tested subsequently by Brain . He also 
tested the  device on his own by using local anaesthesia and also published many 
papers and conducted many studies
3
     
Dr Chandy verghese was another scientist who was eager in these devices 
and he invented many scientific aspects and technical skills related to the 
insertion of these devices in the patients airway eg. Chandy‘s manuever 
           The LMA Classic  soon  received  wide recognition  over time and    
received a standard applause from the anaesthesia community all over the 
world.  After some three years of use in anaesthesia practice , the LMA classic 
was used  by over one third of  anaesthesia providers  bypassing facemask 
ventilation and ETT  for airway management especially in elective short surgical 
procedures
12
  .The  reasons for this observation are, that the supraglottic airway 
devices  and the LMA Classic in particular  are 
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1}  VERSATILE 
2}  USED IN VARIOUS PATIENT  POSITIONS 
3}  REQUIRE LESS SKILLS  
4}  PATIENT SATISFACTION 
5}  LOW FAILURE  and  
6}  LESS INCIDENCES OF POSTOPERATIVE SORE THROAT AND 
DYSPHAGIA 
SAD‘S were generally classified as,  first-generation SADs  and second 
generation SADs devices .First generation devices were developed during the 
period of propofol and with evolution of time devices with new designs, 
functions and sizes  were developed to counter the complications and failure 
rates with first generation devices . This search  for improved SADs  resulted in 
the invention of several new innovative supraglottic airway  devices {second 
generation SADs}
3
. Some of the innovative functions  applied in  second 
generation devices are  
1}  Inbuilt suction tube or drainage tube eg PROSEAL LMA , I-GEL  
2}  More applicable positive pressure ventilation 
3}  Disposability eg .I-GEL 
4}  Integrated bite block eg .I-GEL 
5}  As conduit for endotracheal intubation eg ILMA 
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The  second generation devices has seen a rapid rise in clinical practice  
in last decade.  Although first generation devices were the most used in clinical 
studies and trials , second generation devices are being mostly used in developed 
countries , as they  provide excellent  advantages over the LMA Classic and 
similar devices.After the  LMA classic  became available in 1989 many 
additional devices were added to the LMA equipment family to satisfy specific  
patient needs and a number of other devices were developed  with new 
innovations , designs and functions . There are a large number of supraglottic 
airway devices some of which appears similar to LMA family and others that 
work under a different concept.  
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CLASSIFICATION 
BASED ON THE NUMBER OF LUMEN- 
1. Single Lumen Devices:- 
 LMA-Classic  
 LMA- Unique  
 LMA-Flexible  
 ILMA  
 C-trach  
 Soft seal  
 Laryngeal Airway Device(LAD)  
 Ambu  Laryngeal Mask 
 Pharyngeal airway express(PAX)  
 Cobra Perilaryngeal Airway(CPLA)  
 Laryngeal Tube(LT)  
 Cuffed oropharyngeal airway  
 Stream Lined Liner of the Pharyngeal Airway(SLIPA)  
 Glottic Aperture Seal Device. 
2. Double Lumen Devices:-   
 Proseal LMA  
 Combitube  
 Laryngeal Tube Suction(LTS)  
 Airway Management Device(AMD) 
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3. Triple Lumen Devices:-   
 Elisha Airway Device(EAD)  
BASED ON SEALING MECHANISM   
1 . Cuffed perilaryngeal sealer 
Non-directional non esophageal Sealers  
 Classic  LMA  
 Flexible LMA  
 LMA unique 
Directional Non-esophageal sealing  
 Fastrach LMA  
 ALMA. 
Directional esophageal sealing  
 Proseal LMA  
 Supreme LMA 
2. Cuffed pharyngeal sealer  
          Without esophageal sealing  
 COPA 
 PAX 
With esophageal sealing  
 Combitube   
 Laryngeal tube 
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3. Cuff less preshaped sealer: -  
With esophageal sealing-  
 Baska mask 
 I-gel 
 Without esophageal sealing-   
 SLIPA  {streamlined liner of the pharynx airway}  
 AirQ-SP. 
BASED ON GENERATION 
FIRST GENERATION  
FEATURES 
 Simple airway device  
 Low pressure pharyngeal seal 
 May or may not protect from aspiration 
 Have no specific design to lessen the risk 
 Eg  ; Classic Lma,Flexible Lma, Laryngeal tube,Cobra perilaryngeal 
airway 
SECOND GENERATION  
FEATURES 
 It is specially designed for safety.  
 They provide high pressure pharyngeal seal and reduce the risk of 
aspiration.  
 They may be more efficacious in ventilation  
Examples include Proseal LMA, Supreme LMA, Laryngeal tube suction 
2, Laryngeal tube suction D , I-gel and SLIPA . 
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    INDICATIONS 
 
1}  Recommended as rescue airways in cannot ventilate cannot intubate 
scenarios 
2}  Procedures in outside the operating room procedures like radiotherapy  
and   MRI  and also in diagnostic  and  short  therapeutic procedures  
3}  Head and neck surgeries  
4}  Bronchoscopy  and laser surgery of trachea 
 
CONTRAINDICATIONS 
 
1} Small oral aperture 
2} Any oropharyngeal or hypopharyngeal mass 
3} Esophageal pathology 
4} Full stomach patients  
5}   In patients with poor lung compliance 
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ADVANTAGES OF SAD  
 Increased speed and ease of placement  
 Less requirement of  technical expertise 
 Improved hemodynamic stability 
 Minimal intraocular and intracranial pressure changes during insertion 
 Increased airway tolerance 
 Low frequency of coughing during emergence 
 
DISADVANTAGES 
 Inadequate positive pressure ventilation 
 More chances of aspiration of gastric content 
 Sore throat 
 Vascular compression and nerve damage  
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COMPLICATIONS OF SUPRAGLOTTIC AIRWAY DEVICES 
Complications related to supraglottic airway devices are bound to happen 
and they  became apparent years  after their introduction and  use in clinical 
practice  . Some of the complications are 
1}  FAILURE IN VENTILATION AND OXYGENATION 
2 }  AIRWAY TRAUMA  LIKE TONGUE CONGESTION AND EDEMA 
3 }  ASPIRATION OF  GASTRIC CONTENTS 
4}  COMPRESSION INJURIES TO PHARYNGEAL NERVES AND 
LINGUAL, HYPOGLOSSAL, AND RECURRENT LARYNGEAL 
NERVE 
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TECHNIQUES AND PRECAUTIONS FOR  SUCCESSFUL USE OF 
SUPRAGLOTTIC AIRWAY DEVICES 
The following Techniques and precautions will help improve success 
with use of SADs. 
1}  Selection of correct patient for correct procedure eg; fasted patients with 
normal lung compliance
 
2} Selection of correct size for correct patient{large cuffed SADs tend to 
function better with positive pressure ventilation
4 
3}  Correct  Patient position  for correct device ie, most of the devices require 
morning sniffing position except combitube and ILMA which require 
neutral head position 
4 }  Correct insertion technique  
5}  Correct fixation technique 
6 }  Confirmation of correct placement  ventilation and oxygenation by means 
of clinical assessment , auscultation  and capnography . 
7}  Try to use limited tidal volume by controlling the endtidal carbondioxide 
concentration. 
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8}  Do not use the gastric port if oesophageal trauma ,oesophageal varices , 
upper GI bleed or any coagulopathy is suspected. 
9}  To use safe removal technique{ try to expel the device smoothly and 
when the patient is in deep plane or fully conscious and awake} 
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TECHNIQUES OF LMA INSERTION – CLASSICAL METHOD2 
 
A –  position the patient in slight  head extension and neck flexion and hold 
LMA  in one hand and support the head with other hand  
B –  Hold the device like a pencil with the index finger in the junction between 
cuff and shaft and move against hard palate 
C –  Proceed the device against the posterior pharyngeal wall till a resistance 
is felt  
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D – Move further till your index finger is inside the mouth of the patient and 
hold the shaft of the device with other hand simultaneously taking out the 
index finger  
Confirm the position of the device by   
1 } Clinical judgement  
2 } Auscultation and capnography 
OTHER METHODS OF INSERTION 
TE 
 Partial inflation method 
 180 degree rotation method 
 Laryngoscopy aided method 
 Stylet aided method 
 Insertion from the side of the mouth opening 
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                                         I- GEL 
Second generation Supraglottic airway device designed  by Muhammed 
Nasir a uk based anaesthesiologist . It is developed and marketed by 
Intersurgicals Ltd a UK based company .  It is made of a thermoplastic elastomer 
and the mask is made of a soft polymer.  The device  lack a inflatable cuff.   The 
device is designed to precisely fit into the laryngeal and perilaryngeal 
structures.  The device  provide a greater seal pressure and increased speed of 
insertion  and does not  require  inflation.  It is Cuffless designed for single use . 
The mask is made of a soft polymer and the shape is like that of a inflated LMA 
posteriorly and fits the perilaryngeal structures anteriorly . Other parts of I-GEL 
include a narrow bore oesophageal drain tube ,a wide bore airway tube and a 
Integral bite block  . The size varies from size 1 to size 5 ie from neonates to 
large adults .  It contains an epiglottic rest  at the anterior part of the cuff which 
reduces the possibility of epiglottis ‘down folding’ and airway obstruction14 
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                METHOD OF INSERTION 
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                           SIZES OF I-GEL 
 
 
 
  
•  The I-GEL  Mask is made of a thermoplastic elastomer (SEBS-Styrene 
Ethylene Butadiene Styrene)which is very flexible and the material has a feel 
of human tissue.  The heat of the body activates the gel component of the 
polymer and fits the hypopharynx  that helps the device to rest and also  
helps in covering the perilaryngeal structures
14
 . 
Advantages:- 
• Easy to insert { Because it does not have cuff } 
• Reduced incidence of postoperative dysphagia and sore throat { Because of 
truncated tip }
17
 
• Good emergency rescue device 
• Used as conduit for intubation {Because of wide lumen }16 
• Less chances of gastric aspiration{Because of  presence of gastric channel} 
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INTUBATING LMA (ILMA) 
 Dr. Brain in 1997 developed the Intubating  LMA {ILMA},also 
known as LMA FASTRACH  stemming from the success of LMA classic
11
. It 
was designed to allow  for  endotracheal intubation
15
 .LMA Fastrach  consists of 
a large internal diameter to allow ETT, a rigid airway tube, an epiglottic 
elevating bar, and a tracheal tube guiding ramp.  The Intubating LMA is not 
intended for intubation with paediatric endotracheal tubes
27
 . 
CHARECTERISTICS ; It is 
• A modification of the C-LMA. 
• Has a rigid (stainless steel) anatomically Cuved, Short & wide bored shaft 
that follows the  curve of the Hard palate and the posterior  pharyngeal wall
30
 
• An  epiglottic  elevator bar at the mask aperture 
• Armoured flexible ET tube with a longitudinal and a horizontal black line- 
coincides with the epiglottic elevating bar
28
.  
• A stabilizer rod of 25cm 
• Seal pressure is 60 cmH2O 
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•  
  
 
 
 
 
                             ILMA AND ETT SIZE
8 
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Body weight  ILMA size  Air volume  Tracheal 
Tube  
30-50kg  3  20ml  7mm  
50-70kg  4  30ml  7.5mm  
70-100kg  5  40ml  8mm  
 
 INSERTION TECHNIQUE 
• Position: Neutral 
• Hold rigid handle parallel to patient’s chest. 
• Glide the mask along the palate till the straight part of the rigid tube is 
parallel to the chin. 
• Rotate the rigid handle directing towards patient’s nose till it can not be 
advanced. 
• Inflate the cuff & check ventilation.  
• Introduce  ETT with black line facing rigid handle till 15 cm mark. 
• Now grip ILMA handle firmly and lift it forward by few millimeters 
without levering. 
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• Advance the tube using clinical judgment. 
• Inflate the cuff and check for tracheal intubation. 
• After confirmation of tracheal intubation deflate the ILMA cuff. 
• Remove ETT connector 
• Insert the stabilizing rod in the ETT to keep it in place. 
• Remove the ILMA gently over the stabilizing rod until it is clear of the 
oral cavity. 
• Stabilize the ETT to prevent accidental extubation. 
• Remove ILMA and the stabilizing rod. 
•
 Reconnect  ETT connector and the breathing circuit and confirm the 
position again
 
CHANDY S MANEUVER
2 
• They increases the seal pressure and aligns the axes of trachea and FETT. 
• First step : Rotating ILMA in coronal & sagittal plane in an attempt to find  
least resistant ventilation position. 
• Second step : is to grasp the handle and use it to draw LMA forward 2-5 mm 
in a lifting action without levering teeth. 
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ADVANTAGES 
 It is useful in cannot ventilate  and cannot  intubate  scenarios.  
 It allows fast insertion into correct position without moving head and 
neck. 
 It can be used alone or can be used as a guide to intubation.  
 It facilitates ventilation between intubating LMA and ETT insertion.  
 It is used as a  conduit for fiberoptic intubation in the presence of 
airway pathology or any mass in the oral cavity 
6
 
 DISADVANTAGES 
It is more likely to dislodge in head and neck manipulation.  
It is unsuitable for MRI. 
It is difficult in insertion with limited mouth opening. On removal of ILMA  
tracheal tube can be displaced  downwards. 
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                                  REVIEW OF LITERATURE  
1. Halwagi et al 2012 and Sastre et al  in 2012  demonstrated 100% 
success rate for I-GEL and ILMA as ventilatory devices.
1
 They conducted study 
in 100 subjects .In this  study a higher success rate was achieved in blind 
tracheal intubation with ILMA group compared to I-GEL group .Intubation  was 
successfully done in 77.5% cases in first attempt and remainder needed second 
attempt by using some maneuvers. In the present study, the conclusion was that 
the  time needed for successful lung ventilation and blind tracheal intubation was 
shorter in ILMA group than I-GEL group  which was statistically significant 
(p<0.05)
5
     
2. Kleine- Brueggeney et al 2011  studied the ease of insertion and 
blind endotracheal intubation in I-GEL and ILMA
7
 . The total study subjects 
were 80 patients  He observed that ease of insertion of SAD  , blind endotracheal 
intubation using I-GEL and ILMA , laryngeal grading using supraglottic airway 
devices I-GEL and  ILMA according to fibreoptic view 
5
. It was concluded that 
blind intubation using ILMA was better than I-GEL since the p value derived 
was also significant <0.0001 using unpaired  t test . 
Laryngeal grading according to fibreoptic view was also better in I-gel 
group and ease of insertion was better in I-GEL  group
9
 . The difference in 
laryngeal grading in both the groups could be due to presence of the epiglottic 
bar in the ILMA which may cause poorer fibrescopic view and intubation 
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through the device . The I-GEL airway has its epiglottic blocker on the outer 
surface of the bowl, and the fibrescopic view of larynx is usually straight and 
unobstructed[7]. In I-gel group, in the cases in which blind tracheal 
intubation failed (9 patients) even after maneuvers, needed stylet for 
intubation with Macintosh laryngoscope. The laryngeal grading in most of 
these patients (7 patients) were grade II according to Cormack Lehane 
grading system
4
.   
3. Keijer et al 2009   observed the incidence of sore throat , dysphagia 
in I-GEL  and ILMA  studying in 100 patients .  He observed that the  incidence 
of sore throat was lesser in I-gel group as compared to ILMA group
5
  In the 
present study ,the incidence of dysphagia,   hoarseness , lip trauma , dental 
trauma  was absent in both the groups
1.
     
4. Theiler et al (2011)   studied “visualized blind intubation” through 
the I-gel and the LMA Fastrach in patient presenting with at least one criterion 
for difficult intubation. The study was carried out in 100 patients . Their results 
demonstrated a substantially poor success rate (15%) with I-gel as compared 
with the LMA Fastrach (69%)
5
 .The success rate of tracheal intubation on the 
first attempt with the LMA Fastrach, as reported in earlier randomized controlled 
trials, varies between 48% to 87%  
22
 .  Results of the present study have shown 
comparable success rate for tracheal intubation with PVC  ETTs through both 
the types of SADs
1
 .                                                                                         
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5. Sameer kapoor et al and Dharma das gupta et al  2014   conducted  
study in 100 patients  , comparing   the ease of insertion of ILMA and I-GEL and 
blind endotracheal intubation using ILMA and I-GEL,they observed  a overall 
success rate of insertion of  supraglottic devices in both the groups was 100% 
which was similar to various previously conducted studies.  In this study, 
first‑ attempt success rate for blind tracheal intubation was comparable in both 
the groups and overall success rate was higher in LMA FASTRACH group as 
compared to I-GEL group
1
 . In I-GEL group the success rate improved with 
external laryngeal manipulation
18
 .  In group ILMA, ETT was inserted with 
reverse orientation as this method resulted in higher success rate . It optimises 
the ETT with the angle of trachea resulting in better first‑ attempt success rate of 
ETT insertion{10}. They observed that 90° counter‑ clock rotation and  external 
laryngeal maneuver {ELM} resulted in substantially superior results in case of  
I-GEL.The incidence of postoperative complications was comparable in both the 
groups. In this study dysphonia was more in ILMA group
5
 . 
6.  Priyamvada Gupta,et al Dharam Das Jethava,etal Durga  
Jethava et al  in 2008 evaluated the success rate of blind tracheal intubation 
through two different SADs I-gel and LMA Fastrach. The complications if any 
were also studied: A total of 100 patients undergoing elective surgery under 
general anaesthesia were randomised in two groups comprising of 50 patients 
each to tracheal intubation using either i-gel (I group) or LMA Fastrach (F 
group).The  Results  showed that  there was no difference in the incidence of 
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adequate ventilation with either of the SAD{1}. The success rate of tracheal 
intubation in first attempt was 66% in Group I and 74% in Group F, while 
overall success rate of tracheal intubation was 82% in Group I when compared 
to 96% in Group F. Time taken for successful tracheal intubation through LMA 
Fastrach was lesser (20.96 s) when compared to i-gel (24.04 s)
10
. Complication 
rates were statistically similar in both the groups.They concluded that  I-gel is a 
better device for rescue ventilation due to its quick insertion but an inferior 
intubating device in comparison to LMA Fastrach
5
 . 
7. Theodora et al in 2013 Investigated whether nursing staff can 
successfully use the I-gel and the Intubating laryngeal mask  airway (ILMA) 
{LMA FASTRACH } during cardiopulmonary resuscitation.Forty five nurses 
inserted the I-gel and the ILMA in a mannequin  with continuous and without 
chest compressions. Mean intubation times for the ILMA and I-gel without chest 
compressions were 20.60 ± 3.27 and 18.40 ± 3.26 s, respectively (p < 0.0005). 
ILMA proved more successful than the I-gel regardless of compressions. 
Continuation of compressions caused a prolongation in intubation times for both 
the I-gel (p < 0.0005) and the ILMA (p < 0.0005) . In this mannequin study, it 
was concluded that nursing staff can successfully intubate using the I-gel and the 
ILMA as conduits with comparable success rates, regardless of whether chest 
compressions given or not given 
 
31 | P a g e  
 
8} Jatin  Lal et al in  2015  evaluated I-gel to be used as an  effective 
ventilatory device and as a conduit for endotracheal intubation. After informed 
consent, 50 ASA I-II adults with normal airways undergoing elective surgery 
under general anaesthesia requiring intubation were allocated to undergo blind 
tracheal intubation using i-gel
25
. 
I-gel insertion was successful in all 50 (100%) patients [46 (92%) in 1
st
, 3 
(6%) in 2
nd
 and 1(2%) in 3
rd
 attempt]. The mean duration  of insertion of i-gel 
was 18.20 ±2.32 seconds. The mean airway seal pressure was 26.78 ± 4.10 cm 
H2O. Overall successful  rate of intubation through i-gel was 78% [34(68%) in 
1
st
, 3(6%) in 2
nd
 and 2(4%) in 3
rd
 attempt]. The mean time for intubation using i-
gel was 23.28 ± 8.22 seconds.They concluded that I-gel provides effective 
ventilation with acceptable airway seal pressures and can serve as alternative 
conduit for blind endotracheal intubation
24
. 
9}  Uppal et al ‘Fletcher et al and Kinsella et al in 2008  assessed  the 
ability of I-gel  to provide pressure-controlled ventilation (PCV) during 
anaesthesia .It was assessed  by measuring the gas leaks and comparing these 
values with that of the tracheal tube
17
.  
Twenty-five patients, ASA I–II, were recruited to the study. Patients 
received a standard anaesthetic technique followed by an initial placement of the 
i-gel. The lungs were then ventilated at three different pressures (15, 20, 25 cm 
H2O) using PCV. There was no significant difference between the leak fractions 
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of the i-gel and the tracheal tube at 15 and 20 cm H2O PCV. At 25 cm H2O, the 
median difference in leak fraction was 0.02 (P=0.014) and the median difference 
in leak volume was 26.5 ml (P=0.006). There was no evidence of gastric 
insufflations with any of the pressures used during PCV.  
10} Michalek et al,  W.  Donaldson et al ,Graham et al 2014   studied 
the comparison of I-GEL and ILMA as a conduit for blind tracheal intubation in 
three different airway mannequins 
5
.  A prospective study with 25 participants 
evaluated the success rate of blind intubation (using a gum-elastic bougie, an 
Aintree intubating catheter (AIC) and designated tracheal tube) and fibrescope-
guided tracheal intubation (through the intubating laryngeal mask airway and the 
I-GEL supraglottic airway) on three different airway  mannequins
6
  Twenty five 
anaesthetists performed three intubations with each method on each of three 
mannequins.The success rate of FOB guided technique was significantly higher 
than blind attempts with both devices
19
. All blind techniques were significantly 
more successful in the ILMA group compared to the I-gel
20
  
11} Brain AI et al  Verghese et al, Addy et al in 1997   assessed the 
efficacy of the intubating laryngeal mask airway (ILMA), as a ventilatory device 
and blind intubation guide. Out of 149 of 150 (99.3%) patients, in 75 (50%) 
patients no resistance was encountered and the trachea was intubated at the first 
attempt, 28 (19%) patients required one adjusting manoeuvre and 46 (31%) 
patients required 2-4 adjusting manoeuvres before intubation was successful. 
There were 13 patients with potential or known airway problems. The lungs of 
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all of these patients were ventilated easily and the trachea intubated using the 
ILMA. In 10 of 13 (77%) of these patients, no resistance was encountered and 
the trachea was intubated at the first attempt; three of 13 (23%) patients required 
one adjusting manoeuvre. Tracheal intubation required significantly fewer 
adjusting manoeuvres in patients with a predicted or known difficult airway (P < 
0.05).  They concluded  that the ILMA appeared on initial assessment to be an 
effective ventilatory device and intubation guide for routine and difficult airway 
patients not at risk of gastric aspiration
10
. 
12} Dimitriou v et al  , Voyagis gs et al 1999  evaluated the efficacy of a 
newly developed  prototype  illuminated flexible catheter to facilitate tracheal 
intubation through the intubating laryngeal mask and compared this light-guided 
technique with the conventional blind tracheal intubation through the intubating 
laryngeal mask. . The success rate for the blind and light-guided technique was 
91% and 100%, respectively (P = 0.003).  They concluded  that the use of an 
illuminated flexible catheter carries advantages either in optimizing the 
intubating laryngeal mask position in the laryngopharynx or in achieving a quick 
and safe light-guided advancement from laryngopharynx into the trachea
6
 . 
13} Young et al 2003  Indicated that  intubating laryngeal-mask airway 
(ILMA) may be an ideal device for airway control in the rural trauma patient. 
The ILMA is an advanced laryngeal-mask airway designed to allow oxygenation 
of the unconscious patient as well as blind tracheal intubation with an 
endotracheal tube.  ILMA has been found to be reliable and successful when 
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other techniques fail, such as fiberoptic intubation and direct laryngoscopy. The 
ILMA has also been reported to cause less hemodynamic change and less injury 
to the teeth and lips than direct laryngoscopy. Further, the ILMA was found to 
be easier and faster to use with a higher success rate than either the combitube or 
endotracheal tube for unskilled healthcare providers. Limitations and 
complications of the ILMA may include aspiration, esophageal intubation, 
damage to the larynx or other tissues during blind passage of a tracheal tube, and 
edema of the epiglottis. 
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MATERIALS AND METHODOLOGY 
TYPE   OF   STUDY      
A prospective,  Comparative  study 
PLACE OF STUDY 
Government Kilpauk Medical College and Hospital 
SAMPLE SIZE  
The formula for calculating sample size is given as  
N  =  {Z1alpha/2 .sigma/E } 2  Where 
N  = sample size 
Sigma = population standard deviation 
E  = margin of error  
Z  = the value for the given confidence interval 
Confidence level is estimated at 95%  
Standard deviation 3.79 
Z value of 1.96  
Margin of error is estimated at +/_1  
Power of study 80 percent 
The sample size calculated was 56.  In my study 60 subjects were taken     
60  adult patients satisfying the inclusion criteria was enrolled in the study. 
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INCLUSION CRITERIA   
1)  Adult  patients undergoing elective surgery requiring general anaesthesia. 
2) ASA physical status 1 – 2  
3) Patients with age >18 years and <60 years  
4) Patients with height:150-180cm 
5) Patients who have given valid informed consent 
6) Patients with MPC I & II 
EXCLUSION CRITERIA 
1) Patients not satisfying inclusion criteria. 
2) Patients requiring techniques such as rapid sequence induction. 
3) Patients with oral pathology with distorted anatomy.  
4) Patients with Trismus/TMJ pathology/ MPC III & IV 
5) Pregnant, Gastroesophageal reflux disease & hiatus hernia  patients 
6) Patients who are unconscious or severely ill. 
7) Morbidly obese patients. 
8) Patients with neck swelling/thyroid. 
9) Patients with post burns contracture neck. 
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MATERIALS : 
1) Anaesthesia machine 
2) Supraglottic airway devices ILMA & I –GEL size 3 & 4  
3) ET Tube of size 7 & 7.5 mm ID 
4)  Laryngoscope with different blade sizes 
The following were kept ready.  
 Anesthesia machine and circuits { checked } 
 Endotracheal tubes → Cuffed Portex tubes of appropriate size  
 Endotracheal tube of one size less { which was used as a modified 
stabilizer rod for I-GEL  since I-GEL  is not provided with a standard 
stabilizer rod } 
  Macintosh laryngoscope → with appropriate and large sized blade.  
 Oral and Nasopharyngeal airway  
 Functioning suction apparatus  
 Monitors → ECG monitor and Pulse oximeter, NIBP ,ETCO2 with 
capnograph  
 Laryngeal mask airway of appropriate size   
 Stabilizer rod for ILMA device 
 Emergency drugs tray  
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METHODOLOGY 
This Study was conducted on 60 patients  undergoing elective surgery 
under general anaesthesia, after getting  approval from  Institutional ethics 
committee. Written informed consent was obtained from all patients. After 
premedication with Ranitidine 50 mg and Metoclopramide 10 mg intravenously 
30 minutes before  induction, patient was  shifted to the operation theatre. In the 
operation theatre, after establishing an  intravenous route,Ringer lactate solution 
was started. Standard monitors were connected eg } NIBP ,ECG ,ETCO2 ,SPO2 
. All patients   received  intravenous Glycopyrrolate 0.2mg, Fentanyl 
2microgram/kg and Midazolam 0.03mg/kg, 10 minutes before induction of 
anaesthesia. . All the patients was preoxygenated with 100% oxygen for 3 
minutes. Induction  was done with appropriate inducing agents and Musle 
relaxation was  facilitated with appropriate Nondepolarising  Muscle relaxants 
and mask ventilation was continued for 3 minutes with mixture of Oxygen,  and 
Nitrous oxide. Depending on body weight the following sizes of the SADs (I-
GEL/ILMA) and endotracheal tube (ETT) were chosen with little change in 
manufacturer’s recommendations  
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Size of SAD 
Patients bodyweight  in 
kilograms 
ETT Internal diameter  
size 
I-GEL   
Size 3 {three } 30-50 kg 7.0mm 
Size 4 {four } 50-90kg 7.5mm 
ILMA  Size 3 {three} 30-50kg 7.0mm 
Size 4{four} 50-70kg 7.5mm 
Size 5  {five} >70kg 7.5mm 
 
Conventional PVC (Polyvinylchloride) endotracheal tube ( Portex ) is 
used for blind endotracheal intubation. Both SADs and ETT are  lubricated with 
2% Lignocaine jelly prior to use. The I-gel supraglottic airway device was 
inserted in extended neck position {classical method }, while the ILMA was  
inserted in neutral neck position. Duration of successful SAD insertion is defined 
as the time elapsed from the insertion of SAD between the dental arches until the 
confirmation of successful ventilation determined by chest wall movement, 
auscultation of breath sounds, capnography and absence of oropharyngeal leak 
with peak airway pressure of > 20 cm of H2O
1
. The time will be measured with 
the help of a stopwatch. The number of attempts required for SAD insertion 
were recorded. A failed attempt is defined as removal of the device from the 
mouth before it is reinserted .If the device is not successfully inserted in third 
attempt this is recorded as failure of SAD insertion. 
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Following this,  blind tracheal intubation is to be attempted through SAD. 
Duration of successful blind tracheal intubation through SAD is defined as the 
time elapsed from passing the ETT through SAD until the confirmation of 
successful ventilation, which is determined by chest rise, auscultation of breath 
sounds and capnography. In I-GEL group, SAD was  removed using one size 
smaller tracheal tube. {In case of I-GEL since it is not provided with the 
stabilizer rod }   In ILMA group ETT was removed using the stabilizer rod 
provided along with the ILMA set . 
When resistance is felt during ETT Insertion in I-GEL group following 
manuevers can be used 
1.  ETT was rotated 90 degree counterclockwise and then inserted 
2.   Cricoid pressure
26 
IN ILMA group ETT , was inserted with  
1. Reverse orientation, 
2. Inserted with conventional technique and then rotated through 180 degree 
once it crosses the proximal opening in LMA 
1 
In both the study groups, maximum three attempts at device insertion and 
maximum three attempts at tracheal intubation were allowed. If tracheal 
intubation through the device is unsuccessful, it was performed by direct 
laryngoscopy or the procedure was completed with the SAD in place depending 
on the implications and need of the surgical procedure  
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PARAMETERS ANALYSED 
EASE OF INSERTION BASED ON SUBJECTIVE SCORE 
Easy    - score 1 
Satisfactory - score 2 
Diifficult   - score 3 
NUMBER OF ATTEMPTS FOR SAD INSERTION AND BLIND 
TRACHEAL INTUBATION  
 Maximum of three attempts each for SAD insertion and ETT insertion 
were done .More than three attempts taken, was considered  failure. 
DURATION FOR INSERTION OF SAD AND BLIND TRACHEAL 
INTUBATION 
 Calculated from the time duration that  elapsed from passage of  SAD  
through the dental arches  and ETT through the SAD to the confirmation of  
successful ventilation  confirmed  clinically and by  Endtidal carbondioxide 
concentration monitoring.  
THE PRESENCE OR ABSENCE  OF POSTOPERATIVE DYSPHAGIA, 
SORETHROAT ,HOARSENESS OF VOICE etc  
Was enquired at the end of the procedure.  
           All patients were observed in the recovery room for half an hour            
postoperatively and  shifted to postoperative ward for further care . 
All recorded data were collected and statistical analysis were done. 
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OBSERVATION AND RESULTS –STATISTICAL ANALYSIS 
This prospective non randomized, double arm, single blinded, 
Comparative  study was done to evaluate the efficacy of  supraglottic airway 
devices I-GEL and ILMA  as  emergency ventilatory devices and their  ability as 
conduit for blind intubation
10
 . 
All data were collected and tabulated 
GROUPS  
Groups Intervention Number 
ILMA Group 
ILMA  ( 30 ) inserted after 3 min ventilation 
followed by blind ETT intubation 
30 
I-GEL Group 
I GEL    (30) inserted after 3 min ventilation 
followed by blind ETT intubation 
30 
 
Descriptive statistics was done for all data and were reported in terms of 
mean values and percentages. Suitable statistical tests of comparison were done. 
Continuous variables were analysed with the unpaired t test.. Categorical 
variables were analysed with the Chi-Square Test and Fisher Exact Test. 
Statistical significance was taken as P < 0.05. The data was analysed using SPSS 
version 16 and Microsoft Excel 2007
10
. 
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AGE 
 
 
Age - Groups ILMA Group % I-GEL Group % 
≤ 20 years 3 10.00 3 10.00 
21-30 years 13 43.33 13 43.33 
31-40 years 9 30.00 9 30.00 
41-50 years 3 10.00 4 13.33 
51-60 years 2 6.67 1 3.33 
Total 30 100 30 100 
 
Age Distribution ILMA Group I-GEL Group 
Mean 30.50 30.60 
SD 9.92 8.59 
P value  
Unpaired t Test 
0.9669 
 
Majority of the ILMA group patients belonged to 21-30 years age class 
interval (n=13, 43.33%) with a mean age of 30.50 years. In the I-GEL group 
patients, majority belonged to 21-30 years class interval (n=13, 43.33%) with a 
mean age of 30.60 years. The association between the intervention groups and 
age distribution is considered to be not statistically significant since p > 0.05 as 
per unpaired t test. 
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GENDER  
 
 
 
Gender - Groups ILMA Group % I-GEL Group % 
Male 11 36.67 12 40.00 
Female 19 63.33 18 60.00 
Total 30 100 30 100 
P value 
Chi Square Test 
0.7906 
 
Majority of the ILMA group patients belonged to female gender (n=19, 
63.33%). In the I-GEL group patients, majority too belonged to female gender 
(n=18, 60.00%). The association between the intervention groups and gender 
status is considered to be not statistically significant since p > 0.05 as per chi 
squared test. 
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ASA 
 
 
 
ASA Status - Groups ILMA Group % I-GEL Group % 
ASA 1 25 83.33 22 73.33 
ASA 2 5 16.67 8 26.67 
Total 30 100 30 100 
P value 
Chi Square Test 
0.3472 
 
Majority of the I-LMA group patients belonged to ASA 1(n=25, 83.33%). 
In the i-Gel group patients, majority too belonged to ASA 1 (n=22, 73.33%). 
The association between the intervention groups and ASA status is considered to 
be not statistically significant since p > 0.05 as per chi square test. 
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WEIGHT  
 
 
 
Weight - Groups ILMA Group % I-GEL Group % 
≤ 40 kgs 0 0.00 1 3.33 
41-50 kgs 4 13.33 8 26.67 
51-60 kgs 17 56.67 14 46.67 
61-70 kgs 9 30.00 7 23.33 
Total 30 100 30 100 
 
Weight Distribution ILMA Group I-GEL Group 
Mean 57.10 54.13 
SD 6.54 7.41 
P value 
Unpaired t Test 
0.1055 
 
Majority of the ILMA group patients belonged to 51-60 kgs weight class 
interval (n=17, 56.67%) with a mean weight of 57.10 kgs. In the I-GEL group 
patients, majority belonged to 51-60 kgs weight class interval (n=14, 46.67%) 
with a mean weight of 54.13 kgs. The association between the intervention 
groups and weight distribution is considered to be not statistically significant 
since p > 0.05 as per unpaired t test. 
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HEIGHT  
 
 
Height - Groups ILMA Group % I-GEL Group % 
≤ 150 cms 3 10.00 3 10.00 
151-160 cms 22 73.33 21 70.00 
161-170 cms 5 16.67 6 20.00 
Total 30 100 30 100 
 
Height Distribution ILMA Group I-GEL Group 
Mean 156.73 156.77 
SD 4.79 5.29 
P value 
Unpaired t Test 
0.9797 
 
              Majority of the ILMA group patients belonged to 151-160 cms height 
class interval (n=22, 73.33%) with a mean height of 156.73 cms. In the I-GEL 
group patients, majority belonged to 151-160 cms height class interval (n=21, 
70.00%) with a mean height of 156.73 cms. The association between the 
intervention groups and height distribution is considered to be not statistically 
significant since p > 0.05 as per unpaired t test. 
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DIAGNOSIS  
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Diagnosis 
ILMA 
Group 
% 
I-GEL 
Group 
% 
1 Infertility 3 10.00 4 13.33 
2 Infertility 1 3.33 1 3.33 
Dermoid Cyst Scapula 1 3.33 3 10.00 
DUB 3 10.00 0 0.00 
Fibroadenoma 8 26.67 8 26.67 
Lipoma 3 10.00 0 0.00 
P2L2 1 3.33 2 6.67 
Subacute Appendicitis 7 23.33 3 10.00 
Tuberculosis Abscess 0 0.00 2 6.67 
Others 3 10.00 7 23.33 
Total 30 100 30 100 
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PROCEDURE 
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Procedure 
ILMA 
Group 
% 
I-GEL 
Group 
% 
DHL 6 20.00 6 20.00 
Excision 13 43.33 12 40.00 
Fractional Curettage 3 10.00 0 0.00 
Lap Appendicectomy 7 23.33 4 13.33 
Lap Cholecystectomy 0 0.00 1 3.33 
Lap Hernia Repair 0 0.00 1 3.33 
Lap Sterlization 0 0.00 2 6.67 
Diagnostic Lap 1 3.33 0 0.00 
ORIF 0 0.00 1 3.33 
Others 0 0.00 3 10.00 
Total 30 100 30 100 
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EASE OF INSERTION SCORE 
 
 
 
Ease of Insertion 
Score - Groups 
ILMA Group % 
I-GEL 
Group 
% 
Score 1 1 3.33 21 70.00 
Score 2 16 53.33 9 30.00 
Score 3 13 43.33 0 0.00 
Total 30 100 30 100 
P value 
Fishers Exact Test 
<0.0001 
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By conventional criteria the association between the intervention groups 
and ease of insertion score is considered to be statistically significant since  
p < 0.05.  
Results  
Majority of the ILMA group patients had ease of insertion score 2  
(n=16, 53.33%). In the i-Gel group patients, majority had ease of insertion score 
1 (n=21, 70.00%).  The decreased incidence of  ease of insertion score 1(easy) in 
ILMA group compared to the I-GEL group is considered to be statistically 
significant with a p value of <0.0001 as per fishers exact test. 
Discussion  
The incidence of ease of insertion score 1(easy) was meaningfully less in 
ILMA group compared to the I-GEL group by percentage difference of 66.67 
percentage points ( 95% decrease). This difference is true and significant and has 
not occurred by chance. 
Inference  
In this study the ease of insertion score was significantly and consistently 
lower in I-GEL group compared to the ILMA group when used for ease of 
insertion and as conduit for blind end tracheal intubation. 
In other words I-GEL was 21 times more easier to insert compared to  
ILMA based on statistically significant ease of insertion score. 
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NUMBER OF ATTEMPTS FOR SAD INSERTION 
 
 
 
Number of Attempts for 
SAD Insertion - Groups 
ILMA 
Group 
% 
I-GEL 
Group 
% 
One Attempt 1 3.33 19 63.33 
Two  Attempts 17 56.67 11 36.67 
Three Attempts 9 30.00 0 0.00 
>  Three Attempts 3 10.00 0 0.00 
Total 30 100 30 100 
P value 
Fishers Exact Test 
<0.0001 
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By conventional criteria the association between the intervention groups 
and number of attempts for SAD insertion is considered to be statistically 
significant since p < 0.05.  
Results  
Majority of the ILMA group patients had 2 attempts for SAD insertion 
(n=17, 56.67%). In the I-GEL group patients, majority had 1 attempts for SAD 
insertion (n=19, 63.33%).  The increased number of attempts for SAD insertion 
in ILMA group compared to the I-GEL group is considered to be statistically 
significant with a p value of <0.0001 as per Fishers exact test. 
Discussion  
The incidence of SAD insertion on first attempt was meaningfully less in 
ILMA group compared to the I-GEL group by percentage difference of 60.00 
percentage points ( 95% decrease). This difference is true and significant and has 
not occurred by chance. 
Inference  
In this study the SAD insertion on first attempt was significantly and 
consistently higher in I-GEL group compared to the ILMA group when used for 
ease of insertion .In other words I-GEL had 19 times more successful insertion 
on first attempt success rate compared to  ILMA based on statistically significant 
number of attempts for SAD insertion status. 
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DURATION FOR SAD INSERTION 
 
 
 
Duration for SAD 
Insertion - Groups 
ILMA Group % I-GEL Group % 
≤ 5 secs 0 0.00 11 36.67 
6-10 secs 4 13.33 19 63.33 
11-15 secs 15 50.00 0 0.00 
16-20 secs 8 26.67 0 0.00 
> 20 secs 3 10.00 0 0.00 
Total 30 100 30 100 
 
Duration for SAD Insertion ILMA Group I-GEL Group 
Mean 14.90 6.70 
SD 4.52 2.17 
P value 
Unpaired t Test 
<0.0001 
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By conventional criteria the association between the intervention groups 
and duration for SAD insertion is considered to be statistically significant since  
p < 0.05.  
Results  
Majority of the ILMA group patients had 11-15 secs as duration for 
SGAD insertion (n=15, 50.00%) with a mean of 14.90 secs . In the I-GEL group 
patients, majority had 6-10 secs as duration for SGAD insertion (n=19, 63.33%) 
with a mean of 6.70 secs.  The increased mean duration for SGAD insertion in 
ILMA group compared to the I-GEL group is considered to be statistically 
significant with a p value of <0.0001 as per unpaired t test. 
Discussion  
The mean duration for SGAD insertion was meaningfully more in ILMA 
group compared to the I-GEL group by mean difference of 8.20 secs ( 55% 
increase). This difference is true and significant and has not occurred by chance. 
Inference 
In this study the mean duration for SGAD insertion was significantly and 
consistently lower in I-GEL group compared to the I-LMA group when used for 
ease of insertion .In other words  ILMA needed  2.2 more time duration for SAD 
insertion compared to I-GEL based on statistically significant duration for SAD 
insertion distribution. 
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NUMBER OF ATTEMPTS FOR ETT INSERTION 
 
 
 
Number of Attempts for 
ETT Insertion - Groups 
ILMA 
Group 
% 
I-GEL 
Group 
% 
No Attempt 3 10.00 0 0.00 
One Attempt 22 73.33 1 3.33 
Two  Attempts 5 16.67 18 60.00 
Three Attempts 0 0.00 8 26.67 
>  Three Attempts 0 0.00 3 10.00 
Total 30 100 30 100 
P value 
Fishers Exact Test 
<0.0001 
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By conventional criteria the association between the intervention groups 
and number of attempts for ETT insertion is considered to be statistically 
significant since p < 0.05.  
Results  
Majority of the ILMA group patients had 1 attempt for ETT insertion 
(n=22, 73.33%). In the I-GEL group patients, majority had 2 attempts for ETT 
insertion (n=18, 60.00%).  The decreased number of attempts for ETT insertion 
in ILMA group compared to the I-GEL group is considered to be statistically 
significant with a p value of <0.0001 as per fishers exact test. 
Discussion  
The incidence of ETT insertion on first attempt was meaningfully more in 
I-LMA group compared to the I-GEL group by percentage difference of 70.00 
percentage points ( 95% increase). This difference is true and significant and has 
not occurred by chance. 
Inference 
In this study the ETT insertion on first attempt was significantly and 
consistently lower in I-GEL group compared to the ILMA group when used as 
conduit for blind end tracheal intubation.In other words ILMA had 22 times 
more SAD insertion on first attempt success rate compared to  I-GEL based on 
statistically significant number of attempts for ETT insertion status. 
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DURATION FOR ETT INSERTION 
 
 
Duration for ETT 
Insertion - Groups 
ILMA Group % I-GEL Group % 
No Attempt 3 10.00 0 0.00 
≤ 5 sec 10 33.33 0 0.00 
6-10 sec 15 50.00 1 3.33 
11-15 secs 2 6.67 16 53.33 
16-20 sec 0 0.00 10 33.33 
> 20 sec 0 0.00 3 10.00 
Total 30 100 30 100 
 
Duration for ETT Insertion ILMA Group I-GEL Group 
Mean 5.90 12.90 
SD 3.08 5.10 
P value 
Unpaired t Test 
<0.0001 
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By conventional criteria the association between the intervention groups 
and duration for ETT insertion is considered to be statistically significant since  
p < 0.05.  
Results  
Majority of the ILMA group patients had 6-10 secs as duration for ETT 
insertion (n=15, 50.00%) with a mean of 5.90 secs . In the I-GEL group patients, 
majority had 11-15 secs as duration for ETT insertion (n=16, 53.33%) with a 
mean of 12.90 secs.  The decreased mean duration for ETT insertion in ILMA 
group compared to the I-GEL  group is considered to be statistically significant 
with a p value of <0.0001 as per unpaired t test. 
Discussion  
The mean duration for ETT insertion was meaningfully less in ILMA 
group compared to the I-GEL group by mean difference of 7.00 secs ( 54% 
decrease). This difference is true and significant and has not occurred by chance. 
Inference 
In this study the mean duration for ETT insertion was significantly and 
consistently higher in I-GEL group compared to the ILMA group when used  as 
conduit for blind end tracheal intubation.In other words I-GEL needed 2.19 more 
time duration for ETT insertion compared to ILMA based on statistically 
significant duration for ETT insertion distribution. 
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Failure of SAD Insertion (more than 3 attempts) 
 
 
 
Failure of SAD Insertion 
(more than 3 attempts) 
ILMA Group % I-GEL Group % 
Yes 3 10.00 0 0.00 
No 27 90.00 30 100.00 
Total 30 100 30 100 
P value 
Fishers Exact Test 
0.1186 
 
Majority of the ILMA group patients belonged to failure of SAD less than 
three attempts status (n=27, 90.00%). In the I-GEL group patients, majority too 
belonged to failure of SAD less than three attempts status (n=30, 100.00%). The 
association between the intervention groups and Failure of SAD Insertion (more 
than 3 attempts) status is considered to be not statistically significant since p > 
0.05 as per chi squared test. 
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Failure of Blind Endotracheal Intubation 
 
 
 
Failure of Blind 
Endotracheal Intubation 
ILMA 
Group 
% I-GEL Group % 
Yes 0 0.00 3 10.00 
No 30 100.00 27 90.00 
Total 30 100 30 100 
P value 
Fishers Exact Test 
0.1186 
 
Majority of the ILMA group patients belonged to no failure of blind 
endotracheal intubation status (n=30, 100.00%). In the I-GEL group patients, 
majority too belonged to no failure of blind endotracheal intubation status (n=27, 
90.00%). The association between the intervention groups and no failure of blind 
endotracheal intubation status is considered to be not statistically significant 
since p > 0.05 as Fishers exact test.  
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Postoperative Dysphagia/Sore Throat 
 
 
 
Postoperative 
Dysphagia/Sore 
Throat 
ILMA 
Group 
% 
I-GEL 
Group 
% 
Yes 14 46.67 5 16.67 
No 16 53.33 25 83.33 
Total 30 100 30 100 
P value 
Fishers Exact Test 
0.0125 
 
By conventional criteria the association between the intervention groups and 
postoperative dysphagia/sore throat status is considered to be statistically 
significant since p < 0.05.  
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Results  
Majority of the ILMA group patients had no postoperative dysphagia/sore 
throat (n=16, 53.33%). In the I-GEL group patients, majority had no 
postoperative dysphagia/sore throat (n=25, 83.33%).  The increased incidence of 
postoperative dysphagia/sore throat in ILMA group compared to the I-GEL 
group is considered to be statistically significant with a p value of 0.0125 as per 
Fishers exact test. 
Discussion  
The incidence of postoperative dysphagia/sore throat was meaningfully 
more in ILMA group compared to the I-GEL group by percentage difference of 
30.00 percentage points ( 64% increase). This difference is true and significant 
and has not occurred by chance. 
Inference 
In this study the incidence of postoperative dysphagia/sore throat was 
significantly and consistently lower in I-GEL group compared to the ILMA 
group when used for ease of insertion and as conduit for blind endo tracheal 
intubation. 
In other words ILMA had 2.80 times more SGAD incidence of 
postoperative dysphagia/sore throat compared to  I-GEL based on statistically 
significant postoperative dysphagia/sore throat status. 
66 | P a g e  
 
DISCUSSION 
Expertise in Airway management is a critical skill in the safe 
administration of anaesthesia
6
 . For managing a difficult airway   some of the pre 
requisites are  
1}  proper airway assessment  
2} Meticulous selection of proper patient and proper preoperative                 
optimization 
3} Selection of well trained and experienced  personnel in airway 
management  
4}  Equipments and devices for safe airway management . 
The major factor in anaesthesia related morbidity is related to difficult 
mask ventilation and difficult intubation . Difficult tracheal intubation { 
successful intubation requiring more than 3 attempts or taking longer than 10 
min }occurs in  one to four percent of the population
6
 . 
Over the past few years there have been much focus on devices to 
decrease  the problem of difficult airway and ventilation . The utmost   problem 
is  inability to oxygenate, ventilate or the combination of these factors .  Over the 
past two decades there have been a search for equipment and devices for 
attenuating the problem of difficult oxygenation and ventilation
6
 . 
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Supraglottic airway devices  are one such innovation discovered and are 
helpful in difficult airways and in emergency life threatening situations .The use 
of supraglottic airway devices as a means of rescue in patients who are difficult 
to intubate or ventilate has increased in the field of anaesthesiology and 
emergency medicine.   
These devices require  
1}   Less technical skills  
2} Associated with less increase in intracranial pressure /intraocular 
pressure /intragastric pressure  
3}  Has good device tolerance   
Many studies were done to evaluate the efficacy of supraglottic airway 
devices as emergency rescue airway devices and also as conduit for blind or 
fibreoptic guided endotracheal intubation. 
The present study was done to compare the supraglottic airway devices I-
GEL and ILMA for ease of insertion to assess their ability to function as 
emergency rescue airway devices and also as a conduit devices for tracheal 
intubation in difficult intubation conditions  
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Demographic Data  
The demographic variables were similar in both groups and there were no 
statistically  significant changes {p> 0.05 } 
OTHER DATAS   
Supraglottic Airway Device {Sad }Ease Of Insertion And Number Of 
Attempts 
In the study conducted by Bhandari et al and Halwagi et al they 
demonstrated 100 percent success rate for both I-GEL and ILMA insertion, 
either in first or second attempt . With first attempt of SAD insertion, the 
successful ventilation rate was 95%  In I-GEL group and in ILMA  group it was 
90% .It was 100 % in both the groups in the second attempt
8
  
In this   study,  70% of patients  {21 patients } in I-GEL group  got a 
score of 1 compared to 3.33% {1 patient} in ILMA group . 9 patients {30%} in 
I-GEL group got a score of 2 while 21 patients {53.3%} in ILMA group got the 
same score . score of 3 was given to  13 patients {43.3%} in ILMA Group while 
in I-GEL group no patients found to be difficult .Regarding the number of 
attempts in ILMA group only one patient {3.33% }was able insert in one attempt 
as compared to 19 patients {63.33% } in I-GEL group . 17 patients {56.67% } in 
ILMA group and 11 patients  {36.67% } in I-GEL group were inserted in the 
second attempt . 9 patients {30 % } in ILMA group needed third attempt where 
as I-GEL group dint needed the third attempt . 3 patients {10 % } in ILMA 
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group needed more than three attempts .From these recordings and analysis it 
can be concluded that  I-GEL was a better device for emergency rescue 
ventilation device when compared to ILMA since the data analysed using 
Fischers exact test  and the p value derived was significant < 0.0001 , in both 
criterias  ie, ease of insertion and number of attempts 
8
 
Duration of insertion of supraglottic airway device: 
 In the study conducted by Bhandari et al they concluded that the time for 
successful ventilation with I-GEL was 20.92 seconds and 31.75 seconds in 
ILMA group {p < 0.001 }. In my study only 4 patients  13. 33 % needed less 
than 10 seconds for insertion while all other patients needed more than 10 
seconds. In  I-GEL group all patients {100 % } were inserted in less than 10 
seconds. Thus it can be concluded from the above data and analysis I GEL was 
the better device for  emergency rescue ventilation  since the p value derived 
using unpaired t test  was significant p < 0.0001 . 
Blind  Endotracheal  Intubation 
In the study conducted by Bhandari et al ,first  attempt success rate for 
blind tracheal intubation was comparable in both the groups and overall success 
rate in second attempt was higher in i-gel group as compared to ILMA group, 
unlike the results of Halwagi et al (2012) and Sastre et al (2012) who noticed 
higher success rate of blind tracheal intubation with ILMA. Bhandari et al 
observed that time for successful intubation through I-GEL  was 20.41 seconds 
and 30 .68 seconds in ILMA group . 
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In my study 22 patients were intubated using ILMA in first attempt 
compared to only one patient in I-GEL . 5 patients  in ILMA group needed 
second attempt and 18 patients in I-GEL group needed the same .8 patients in I-
GEL group needed third attempt but that was not the case in ILMA group . 3 
patients in ILMA group were not attempted intubation since the insertion of 
SAD took more than three attempts in these patients .In I-GEL group intubation 
failed in three patients . The p value derived using fishers exact test was 
significant < 0.0001  . Also regarding the duration for intubation,  28 patients in 
ILMA group were intubated in less than 10 seconds only 2 patients needed more 
than 10 seconds . In I-GEL group  only 4 patients were intubated in less than 10 
seconds were as 23 patients needed more than 10 seconds . In 3 patients in I-
GEL group intubation attempt failed . Thus it can be concluded that blind 
intubation using ILMA was better than I-GEL since the p value derived was also 
significant <0.0001 using unpaired  t test . 
Failure Of Sad Insertion {More Than 3 Attempts} 
In the study by Bhandari et al, they demonstrated 100% success rate both 
for I-GEL and ILMA and there were no failures in each group . 
In my study regarding SAD insertion  only  3 patients in ILMA group  
needed  more than 3 attempts and they were not attempted  insertion  and was 
considered  as failure . In I-GEL group  all 30 patients were inserted , either in 
the first or second attempt and thus no failures were recorded .Since the majority 
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in each group had  successful SAD insertion, it  can be concluded that the 
association between the intervention groups and Failure of SAD Insertion (more 
than 3 attempts) status is considered to be not statistically significant since p > 
0.05 as per chi squared test. 
Failure Of  Blind Endotracheal tube  Intubation 
In the study by Bhandari et al and Halwagi et al  both demonstrated  a 100 
% success rate  for blind endotracheal intubation in either groups ie I-GEL and 
ILMA . This was done either in the first or second attempt using cricoid pressure 
in case of I-GEL and reverse orientation of the tube in case of ILMA . 
In my study majority of the patients in either group I-GEL and ILMA 
were intubated except in case if I-GEL group where there was 3 failures , 
because these patients needed more than three attempts and also duration went 
past 20 seconds. .Since majority of the patients in both I-GEL and ILMA group 
were blindly intubated  using SAD,  it can be concluded that  the association 
between the intervention groups and  failure of blind endotracheal intubation 
status is considered to be not statistically significant since p > 0.05 as per  fishers 
exact test. 
Postoperative Sore Throat ,Dysphagia , Hoarseness 
In the study by Bhandari et al  there were no incidence of  sore throat or 
dysphagia in either groups{1} . in study conducted by Keijer et al incidence of 
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sore throat was more in ILMA group . Sameer etal concluded that ILMA group 
had more incidence of dysphonia .  
 In my study  14 patients in ILMA group complained of sore throat , 
dysphagia etc whereas only 5 patients in I-GEL group complained so and the p 
value derived was significant p< 0.o125 . By conventional criteria the 
association between the intervention groups and postoperative dysphagia/sore 
throat status is considered to be statistically significant since p < 0.05using  
Fishers exact test and it can be concluded ILMA has more chances of 
postoperative sorethroat and dysphagia. 
CONCLUSION 
It can be safely concluded from above study  results that  I-GEL   is a 
better emergency ventilatory  device comparable to the study by    Kleine- 
Brueggeney et al  and ILMA as better conduit for blind endotracheal intubation   
comparable to the study by Halwagi et al and Sastre etal but unlike  
Bhandari et al
5
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SUMMARY AND CONCLUSION 
TITLE : A Prospective Comparative  study of supraglottic airway devices I-
GEL and ILMA for ease of insertion and as a conduit for blind endotracheal 
intubation
9
 . 
KEYWORDS : Supraglottic airway devices , I-GEL , ILMA , ease of insertion , 
blind endotracheal intubation . 
AIM :   This study is done to evaluate the efficacy of supraglottic airway devices 
I-GEL and ILMA   as emergency ventilatory  devices by comparing  ease of 
insertion and as conduits for blind endotracheal intubation  which can be used in 
difficult intubating conditions . 
METHODS  :  60 patients posted for  surgical procedures under general 
anaesthesia. Patients fulfilling  inclusion criteria were included in the study and 
were  enrolled and analysed.Patients induced with appropriate Induction gents 
and Non depolarizing muscle relaxants and ventilated for 3 min prior to SAD 
insertion and again ventilated for one minute prior to blind ETT intubation 
 Group A – ILMA  ( 30 ) inserted after 3 min ventilation followed by blind ETT 
intubation 
Group B – I GEL    (30) inserted after 3 min ventilation followed by blind ETT 
intubation  
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Variables such as ease of insertion   ,number of attempts  and duration of 
insertion of SADS ,  number of attempts and duration of blind  ETT insertion  
and postoperative sorethroat , dysphagia  etc were compared. 
The collected data were statistically analysed and tabulated . 
RESULTS: 
The statistical analysis tools used in this study for the comparison of 
demographic variables , ease of insertion , number of attempts and duration of 
insertion of SAD ,  number of attempts and duration for ETT  insertion ,failure  
and postoperative sorethroat and dysphagia were chi square test and fishers exact 
test .  The p value derived for ease of insertion , number of attempts ,and 
duration of insertion of SGADS I-GEL and ILMA were p < 0.001  favouring I-
GEL . Likewise the p value derived for number of attempts and duration for ETT 
insertion through I-GEL and ILMA  were p< 0.0001 favouring ILMA . The p 
value derived for incidence of postoperative sore throat and dysphagia was p< 
0.0125 ,favouring  I-GEL . It was concluded that from above results that I-GEL 
is a better device for emergency rescue ventilation because of its ease of 
insertion and lesser incidence of postoperative sore throat and dysphagia as 
compared to ILMA  whereas ILMA is a better device for blind endotracheal 
intubation  compared to I-GEL 
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CONCLUSION 
It can be safely  concluded that I-GEL is easier to insert and a better 
airway device for emergency  rescue ventilation compared to ILMA and ILMA 
is a better conduit for blind endotracheal intubation than I-GEL .    
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ANNEXURES 
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PROFORMA 
 “COMPARISON OF SUPRAGLOTTIC AIRWAY DEVICES I-GEL AND 
ILMA FOR EASE OF INSERTION  AND AS CONDUIT FOR BLIND 
ENDOTRACHEAL INTUBATION” 
Name:    Age/Gender:   IP Number: 
Height: cm             Weight: kg    BMI: 
Date of surgery: 
ASA Physical status:           Co morbidity:             Drug history 
Group A – ILMA  ( 30 ) inserted after 3 min ventilation followed by blind ETT 
intubation 
Group B – I GEL    (30) inserted after 3 min ventilation followed by blind ETT 
intubation  
ASSESSMENT CRITERIA (following parameters will be assessed) 
S.NO: CRITERIAS GROUP A GROUP B 
1.  Ease of insertion of SAD based on 
subjective score 
 Easy            – score 1 
Satisfactory – score 2 
Difficult        – score 3 
  
2.  Number of attempts for SAD insertion   
3. Duration for SAD insertion   
4. No: of attempts for ETT insertion   
5. Duration of ETT insertion   
6. Postoperative dysphagia, hoarseness of 
voice, sorethroat 
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PATIENT CONSENT FORM 
Study Detail  :  COMPARISON OF SUPRAGLOTTIC AIRWAY 
DEVICES, [ILMA] INTUBATING LMA  AND I-GEL 
FOR EASE OF INSERTION AND AS CONDUIT FOR 
BLIND ENDOTRACHEAL   INTUBATION. 
Study centre :  GOVT. KILPAUK MEDICAL COLLEGE HOSPITAL   
Patients Name  :  
Patients Age  : 
Identification Number :  
Patient may check these boxes  
I confirm that I have understood  the purpose of procedure for the above 
study. I have the opportunity to ask question and all my questions and 
doubts have been answered to my complete satisfaction. 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at anytime without giving reason, without my legal 
rights being affected. 
I Understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in 
respect of current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study I agree to this access. 
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However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that 
arise from this study. 
I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with the 
study team and to immediately inform the study staff if I suffer from any 
deterioration in my health or well – being or any unexpected or unusual 
symptoms. 
I hereby consent to participate in this study. 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological tests. 
 
Signature/thumb Impression : Place 
Patients Name and address   :          Date 
Signature of investigator  :         Place 
Study investigator’s Name  :         Date   
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சுய ஒப்புதல் படிவம் 
ஆய்வு செய்யப்படும் தலைப்பு 
                                  
                                    
                   ஐ                  
      ஐ                               
                                      
                                  
                                    
                              
ஆராய்ச்ெி நிலையம்:        மருத்துவத் துறை, 
         மருத்துவக்கல்லூரி அரசு மருத்துவமறை, சென்றை  
பங்கு சபறுபவரின் சபயர்:       உறவு முலற: 
பங்கு சபறுபவரின் எண்: 
பங்கு சபறுபவர் இதலை (√) குறிக்கவும் 
மமமே குைிப்பிட்டுள்ள மருத்துவ ஆய்வின் விவரங்கள் 
எைக்கு விளக்கப்பட்டது. என்னுறடய ெந்மேகங்கறளக் 
மகட்கவும், அேற்காை ேகுந்ே விளக்கங்கறளப் சபைவும் 
வாய்ப்பளிக்கப்பட்டது.  
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நான் இவ்வாய்வில் ேன்ைிச்றெயாகத்ோன் 
பங்மகற்கிமைன். எந்ேக் காரணத்ேிைாமோ எந்ேக் 
கட்டத்ேிலும் எந்ே ெட்ட ெிக்கலுக்கும் உட்படாமல் நான் 
இவ்வாய்வில் இருந்து விேகிக் சகாள்ளோம் என்றும் 
அைிந்து சகாண்மடன். 
இந்ே ஆய்வு ெம்மந்ேமாகவும், மமலும் இது 
ொர்ந்ேஆய்வு மமற்சகாள்ளும்மபாதும், இந்ே ஆய்வில் 
பங்குசபறும் மருத்துவர் என்னுறடய மருத்துவ 
அைிக்றககறளப் பார்ப்பேற்கு என் அனுமேி மேறவயில்றே 
எை அைிந்துசகாள்கிமைன். நான் ஆய்வில் இருந்து விேகிக் 
சகாண்டாலும் இது சபாருந்தும் எை அைிகிமைன். 
இந்ே ஆய்வின் மூேம் கிறடக்கும் ேகவல்கறளயும், 
பரிமொேறை முடிவுகறளயும் மற்றும் ெிகிச்றெ சோடர்பாை 
ேகவல்கறளயும் மருத்துவர் மமற்சகாள்ளும் ஆய்வில் 
பயன்படுத்ேிக் சகாள்ளவும், அறேப் பிரசுரிக்கவும் என் முழு 
மைதுடன் ெம்மேிக்கிமைன். 
இந்ே ஆய்வில் பங்கு சகாள்ள ஒப்புக்சகாள்கிமைன். 
எைக்குக் சகாடுக்கப்பட்ட அைிவுறரகளின் படி 
நடந்துசகாள்வதுடன், இந்ே ஆய்றவ மமற்சகாள்ளும் 
மருத்துவ அணிக்கு உண்றமயுடன் இருப்மபன் என்றும் 
உறுேியளிக்கிமைன். என் உடல் நேம் பாேிக்கப்பட்டாமோ 
அல்ேது எேிர்பாராே வழக்கத்ேிற்கு மாைாக மநாய்க்குைி 
சேன்பட்டாமோ உடமை அறே மருத்துவ அணியிடம் 
சேரிவிப்மபன் எை உறுேி அளிக்கிமைன். 
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இந்ே ஆய்வில்                   
          ஐ                        
ஐ                                
                             
                                    
                               
                            
                                  
செய்து சகாள்ள நான் முழு மைதுடன் ெம்மேிக்கிமைன். 
 
பங்மகற்பவரின் றகசயாப்பம் ....................................................................  
இடம் .............................................. மேேி ........................ 
கட்றடவிரல் மரறக: 
பங்மகற்பவரின் சபயர் மற்றும் விோெம் 
............................................................................................................................................
....... 
ஆய்வாளரின் றகசயாப்பம் .......................................................................... 
இடம் .................................................மேேி ..................... 
ஆய்வாளரின் சபயர் .......................................................................................... 
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INFORMATION TO PARTICIPANTS 
 
Investigator : -  Dr. A.AMALA SAVIO 
Name of the participant : - 
Title : COMPARISON OF SUPRAGLOTTIC AIRWAY DEVICES, 
INTUBATING LMA [ILMA]  AND I-GEL FOR EASE OF INSERTION 
AND AS CONDUIT FOR BLIND ENDOTRACHEAL INTUBATION 
You are invited to take part in this research study. We have got approval from 
the IEC.  You are asked to participate because you satisfy the eligibility criteria. 
What is the purpose of this research? 
In this study ease of insertion of supraglottic airway devices intubating LMA and 
I-GEL and their use as conduit for endotracheal intubation will be compared as 
they are useful in such situation for rescue ventilation when tracheal intubation 
fails 
Discomforts and risks: Postop sore throat, cough, hoarseness of voice as a 
result of intubation can occur. But they can be managed effectively  
Confidentiality: 
Patients who participated in the study and their details will be maintained 
confidentially and at any cost, those details will not be let out  
Right to withdraw : 
Patients  will not be forced to complete the study. At any cost, in such 
circumstances the treatment  will not be compromised. 
Date :     Signature of the investigator: - 
Place :     Signature/Thumb impression 
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MASTER CHARTS 
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KEY TO MASTER CHART 
 
ETT : ENDOTRACHEAL TUBE 
SAD : SUPRAGLOTTIC AIRWAY DEVICE 
LAP : LAPROSCOPIC 
DUB : DYSFUNCTIONAL UTERINE BLEEDING 
DHL : DIAGNOSTIC  HYSTERO LAPROSCOPY  
ORIF : OPEN REDUCTION AND INTERNAL FIXATION 
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ABBREVIATIONS 
 
 
ASA  - American society of anaesthesiologists 
ETCO2 - Endtidal carbondioxide 
ETT  - Endotracheal tube 
ILMA  - Intubating laryngeal mask airway 
NDMR  - Non-depolarising muscle relaxants 
SAD  - Supraglottic airway device 
 
 
S.NO name AGE SEX
ASA
 STATUS
weight 
IN KGS
HEIGHT 
IN CM
DIAGNOSIS PROCEDURE ANAESTHESIA
EASE OF
 INSERTION
SCORE
NO OF 
ATTEMPTS
FOR SAD 
INSERTION
DURATION 
OF SAD 
IINSERTION
NO OF 
ATTEMPTS 
FOR ETT 
INSERTION
DURATION
 FOR  ETT 
INSERTION 
(SEC)
FAILURE OF 
ETT INSERTION
YES / NO
POST OF 
DYSPHAGIA,
SORETHROAT
1 BHUVANA 18 F 1 40 150 FIBROADENOMA EXCISION GA 2 1 6 1 8 NO NIL
2 KEERTHANA 17 F 1 48 152 FIBROADENOMA EXCISION GA 1 1 5 2 12 NO NIL
3 RAJESH 28 M 2 52 164 ACUTE APPENDICITIS LAP APPENDICECTOMY GA 1 1 6 2 11 NO NIL
4 MONIKA 20 F 1 51 156 FIBROADENOMA EXCISION GA 1 1 4 3 12 NO YES
5 THENMOZHII 29 F 1 56 160 SECONDARY INFERTILITY DHL GA 2 2 10 2 12 NO NIL
6 VIJAYASHANTHI 33 F 1 50 154 FIBROADENOMA EXCISION GA 1 1 4 >3 YES NIL
7 VADIVEL 42 M 2 64 170 CHOLECYSTITIS LAP CHOLECYSTECTOMY GA 1 1 5 3 15 NO NIL
8 SUBALAKSHMI 25 F 1 61 158 1 INFERTILITY DHL GA 1 1 5 2 12 NO NIL
9 VELMURUGAN 42 M 2 60 164 DERMOID CYST SCALP EXCISION GA 1 1 4 3 18 NO NIL
10 BASKER 31 M 1 62 158 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 1 2 8 2 12 NO YES
11 VELAVAN 52 M 2 64 162 DNS FESS GA 2 2 7 3 18 NO NIL
12 PREMA 22 F 1 45 154 FIBROADENOMA EXCISION GA 1 1 4 2 12 NO NIL
13 RAJA 32 M 1 60 164 INGUINAL HERNIA LAP HERNIA REPAIR GA 2 2 9 3 18 NO NIL
14 USHA 26 F 1 45 152 1 INFERTILITY DHL GA 1 1 5 2 14 NO NIL
15 VANAJA 45 F 2 55 154 FRACTURE CLAVICLE ORIF GA 2 2 10 2 14 NO NIL
16 NAVEEN 23 M 1 54 158 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 1 1 4 2 12 NO NIL
17 VAISHALI 27 F 1 45 152 1INFERTILITY DHL GA 1 1 6 3 16 NO NIL
18 GIRIDHARAN 35 M 2 65 158 THYROGLOSSAL CYST EXCISION GA 2 2 10 >3 YES YES
19 VASUKI 37 F 1 52 152 P2L2 LAP STERLISATION GA 1 1 5 2 18 NO NIL
20 SUGANYA 43 F 2 55 148 FIBROADENOMA EXCISION GA 2 2 8 2 14 NO NIL
21 AMALRAJ 28 M 1 54 160 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 1 1 5 2 12 NO NIL
22 NAVAMANI 38 M 1 70 165 DERMOID CYST SCALP EXCISION GA 2 2 10 2 13 NO NIL
23 KAMESHWARI 22 F 1 45 154 FIBROADENOMA EXCISION GA 1 1 6 3 18 NO NIL
24 KALPANA 27 F 1 45 154 1 INFERTILITY DHL GA 2 2 9 2 14 NO YES
25 SELVAMANI 36 M 1 57 160 GYNAECOMASTIA WEBSTER PROCEDURE GA 1 1 6 2 16 NO NIL
26 VANI 22 F 1 45 150 FIBROADENOMA EXCISION GA 1 2 10 2 18 NO NIL
27 JHANSIRANI 35 F 1 54 154 P2L2 LAP STERLISATION GA 1 1 7 >3 YES NIL
28 ANBAZHAGAN 27 M 1 62 160 DERMOID CYST SCALP EXCISION GA 1 2 10 3 18 NO NIL
29 SRIDEVI 24 F 2 54 154 TB ABDOMEN DHL GA 1 1 7 2 14 NO NIL
30 PRABHA 32 F 1 54 152 PBRA CHEST SSG GA 1 1 6 2 16 NO YES
 I GEL SUPRAGLOTTIC AIRWAY DEVICE (SAD) 
S.NO NAME AGE SEX
ASA 
STATUS
weight 
IN KGS
HEIGHT 
IN CM
DIAGNOSIS PROCEDURE ANAESTHESIA
EASE OF 
INSERTION
SUBJECTIVE  
SCORE
NO OF 
ATTEMPTS FOR 
SAD INSERTION
DURATION
 OF SAD 
IN SEC
NO OF 
ATTEMPTS ETT
 INSERTION
DURATION
FOR  ETT 
INSERTION 
 (SEC)
 FAILURE - SAD 
INSERTION
YES / NO
POST OF 
DYSPHAGIA,
SORETHROAT
1 sridevi 20 f 1 53 156 FIBROADENOMA EXCISION GA 2 2 12 1 4 NO PRESENT
2 NAGARANI 34 F 2 60 152 1 INFERTILITY DHL GA 3 3 14 1 3 NO PRESENT
3 JYOTHI 32 F 1 54 160 2 INFERTILITY DHL GA 2 2 9 1 5 NO NIL
4 NAGAJOTHI 28 F 1 54 158 TUBERCULOUS ABSCESS DHL GA 3 >3 >20 YES PRESENT
5 SEVATHA 38 F 1 62 150 1 INFERTILITY DHL GA 2 2 10 1 5 NO PRESENT
6 BHAVANI 24 F 2 61 156 1 INFERTILITY DHL GA 3 3 15 1 4 NO PRESENT
7 MADASAMY 33 M 1 70 164 SEROMA LEFT EAR EXCISION GA 3 3 18 1 5 NO PRESENT
8 PALANIAMMAL 48 F 2 68 160 DUB FRACTIONAL CURETTAGE GA 2 2 14 1 4 NO NIL
9 DEIVANAI 22 F 1 45 152 FIBROADENOMA EXCISION GA 2 2 12 1 5 NO PRESENT
10 ARJUN 32 M 1 56 160 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 3 >3 >20 YES PRESENT
11 LAKSHMI 43 F 1 58 156 DUB FRACTIONAL CURETTAGE GA 2 2 9 2 12 NO PRESENT
12 SATHYA 23 F 1 54 153 FIBROADENOMA EXCISION GA 2 2 12 1 5 NO NIL
13 UDHYABALU 55 M 1 65 166 LIPOMA NECK EXCISION GA 3 2 14 1 5 NO NIL
14 BANUPRIYA 24 F 1 55 154 FIBROADENOMA EXCISION GA 2 2 12 1 6 NO PRESENT
15 KARTHIK 20 M 1 56 158 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 1 1 6 1 6 NO NIL
16 SAMSON 18 M 1 60 156 DERMOID CYST SCAPULA EXCISION GA 3 3 18 1 6 NO PRESENT
17 SATHYAVAN 26 M 1 64 162 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 2 2 13 1 6 NO NIL
18 DURAIRAJ 34 M 1 54 154 LIPOMA BACK EXCISION GA 3 3 18 2 10 NO PRESENT
19 SELVARANI 22 F 1 61 160 FIBROADENOMA EXCISION GA 2 2 14 1 8 NO NIL
20 GEETA 32 F 1 56 161 P2L2 DHL GA 3 3 17 2 10 NO PRESENT
21 MANI 26 M 1 58 166 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 2 2 14 2 10 NO NIL
22 HEMALATHA 33 F 2 45 148 TUBERCULOUS ABSCESS DIAGNOSTIC LAP GA 2 2 12 1 13 NO NIL
23 RADHIKA 23 F 1 45 152 FIBROADENOMA EXCISION GA 2 2 14 1 6 NO PRESENT
24 ANANDRAJ 44 M 1 62 160 LIPOMA FACE EXCISION GA 3 >3 >20 YES PRESENT
25 SIVARAJ 26 F 1 56 156 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 2 2 12 1 7 NO NIL
26 SANGEETHA 22 F 1 45 152 FIBROADENOMA EXCISION GA 3 3 16 1 6 NO PRESENT
27 RAJMOHAN 32 M 1 60 154 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 2 2 15 1 7 NO NIL
28 SEETHALAXMI 24 F 1 54 148 FIBROADENOMA EXCISION GA 3 3 18 2 6 NO PRESENT
29 MARIASELVAM 54 F 2 66 158 DUB FRACTIONAL CURETTAGE GA 3 3 18 1 7 NO NIL
30 VEERASAMY 23 M 1 56 160 SUBACUTE APPENDICITIS LAP APPENDICECTOMY GA 2 2 16 1 6 NO NIL
 I LMA SUPRAGLOTTIC AIRWAY DEVICES (SAD) 
